Replimune Group (REPL) Stock Chart & Stock Price History $12.12 -0.56 (-4.42%) Closing price 03/3/2025 04:00 PM EasternExtended Trading$12.12 0.00 (0.00%) As of 03/3/2025 04:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Replimune Group Stock Price Performance 5 Day Performance-9.18%1 Month Performance-12.29%3 Month Performance-8.49%6 Month Performance+16.97%Year-To-Date Performance-0.70%1 Year Performance+34.06% Receive REPL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Replimune Group and its competitors with MarketBeat's FREE daily newsletter. Email Address REPL Stock Chart for Tuesday, March, 4, 2025 REPL Chart by TradingView Replimune Group Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization02/28/2025$12.64$12.68+0.32%$12.79$11.86952,417 shs$976.55 million02/27/2025$13.24$12.64-4.53%$13.66$12.30839,301 shs$973.47 million02/26/2025$13.49$13.24-1.85%$13.99$13.14514,231 shs$1.02 billion02/25/2025$13.61$13.49-0.88%$13.72$13.09500,688 shs$1.04 billion02/24/2025$13.98$13.61-2.65%$14.43$13.59478,291 shs$1.05 billion02/21/2025$14.31$13.98-2.31%$14.80$13.57674,830 shs$1.08 billion02/20/2025$13.78$14.31+3.85%$14.78$13.401.05 million shs$1.10 billion02/19/2025$14.03$13.78-1.78%$14.45$13.67373,003 shs$1.06 billion02/18/2025$14.10$14.03-0.50%$14.32$13.77374,547 shs$959.93 million02/17/2025$14.10$14.10$14.59$14.07431,744 shs$964.72 million Get the Latest News and Ratings for REPL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Replimune Group and its competitors with MarketBeat's FREE daily newsletter. 02/14/2025$14.29$14.10-1.33%$14.59$14.07431,744 shs$964.72 million02/13/2025$13.79$14.29+3.63%$14.48$13.44503,827 shs$977.72 million02/12/2025$12.85$13.79+7.32%$13.85$12.36930,263 shs$943.51 million02/11/2025$13.12$12.85-2.06%$13.03$12.56371,662 shs$879.20 million02/10/2025$13.94$13.12-5.88%$13.96$13.04679,785 shs$897.67 million02/07/2025$14.06$13.94-0.85%$14.14$13.48598,798 shs$953.73 million02/06/2025$14.25$14.06-1.33%$14.44$13.86483,436 shs$961.99 million02/05/2025$14.01$14.25+1.71%$14.44$13.81593,997 shs$974.99 million02/04/2025$13.71$14.01+2.19%$14.12$13.42423,494 shs$958.56 million02/03/2025$13.98$13.71-1.93%$14.11$13.33631,644 shs$938.04 million Related Companies Organon & Co. Stock Price Chart Ultragenyx Pharmaceutical Stock Price Chart PTC Therapeutics Stock Price Chart ADMA Biologics Stock Price Chart Avidity Biosciences Stock Price Chart Zai Lab Stock Price Chart Biohaven Stock Price Chart Alvotech Stock Price Chart Recursion Pharmaceuticals Stock Price Chart Scholar Rock Stock Price Chart Receive REPL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Replimune Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:REPL) was last updated on 3/4/2025 by MarketBeat.com Staff From Our PartnersHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | Sponsored(1) Elon Musk’s Final Project REVEALEDThe world’s richest man has an ace up his sleeve. You see, while everyone is talking about Elon Musk’s plan...Paradigm Press | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Replimune Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Replimune Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
